Ignite Creation Date:
2025-12-26 @ 5:19 PM
Ignite Modification Date:
2026-01-25 @ 1:40 AM
Study NCT ID:
NCT06018506
Status:
TERMINATED
Last Update Posted:
2025-11-21
First Post:
2023-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of BR108 in Hematological Malignancies
Sponsor:
BioRay Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematologic Malignancy | View |
Keywords: